首页> 美国卫生研究院文献>Journal of the Boston Society of Medical Sciences >Tumor Progression Stage and Anatomical Site Regulate Tumor-Associated Macrophage and Bone Marrow-Derived Monocyte Polarization
【2h】

Tumor Progression Stage and Anatomical Site Regulate Tumor-Associated Macrophage and Bone Marrow-Derived Monocyte Polarization

机译:肿瘤进展阶段和解剖部位调节肿瘤相关的巨噬细胞和骨髓衍生的单核细胞极化。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Tumor-associated macrophages (TAMs) encourage and coordinate neoplastic growth. In late stage human lung adenocarcinoma, TAMs exhibited mixed M1 (classical; argIlowiNOShigh) and M2 (alternative; argIhighiNOSlow) polarization based on arginine metabolism. In several murine cancer models including chemically and genetically-induced primary lung tumors, prostate tumors, colon xenografts, and lung metastases, TAMs expressed argIhighiNOSlow early during tumor formation; argIlowiNOShigh polarization also occurred during malignancy in some models. In a chemically-induced lung tumor model, macrophages expressed argIhighiNOSlow within one week after carcinogen treatment, followed by similar polarization of bone marrow–derived monocytes (BDMCs) a few days later. TAMs surrounding murine prostate tumors also expressed argIhighiNOSlow early during tumorigenesis, indicating that this polarization is not unique to neoplastic lungs. In a human colon cancer xenograft model, the primary tumor was surrounded by argIhighiNOSlow-expressing TAMs, and BDMCs also expressed argIhighiNOSlow, but pulmonary macrophages adopted argIhighiNOSlow polarization only after tumors metastasized to the lungs. Persistence of tumors is required to maintain TAM polarization. Indeed, in both conditional mutant >Kras- and >FGF10-driven models of lung cancer, mice expressing the transgene develop lung tumors that regress rapidly when the transgene is silenced. Furthermore, pulmonary macrophages expressed argIhighiNOSlow on tumor induction, but then returned to argIlow iNOSlow (no polarization) after tumors regressed. Manipulating TAM function or depleting TAMs may provide novel therapeutic strategies for preventing and treating many types of cancer.
机译:肿瘤相关的巨噬细胞(TAMs)促进并协调肿瘤的生长。在晚期人肺腺癌中,TAM显示出混合的M1(经典; argI low iNOS high )和M2(替代品:argI high i iNOS )基于精氨酸代谢的极化在一些鼠类癌症模型中,包括化学和基因诱导的原发性肺肿瘤,前列腺肿瘤,结肠异种移植和肺转移,TAM在肿瘤形成的早期表达argI iNOS low 。在某些模型中,argI low iNOS high 极化也发生了。在化学诱导的肺肿瘤模型中,巨噬细胞在致癌剂治疗后一周内表达argI i SNOS i i i low ,随后出现类似的骨髓源性单核细胞(BDMC)极化几天后。鼠前列腺肿瘤周围的TAM在肿瘤发生的早期也表达argI i iNOS low ,这表明这种极化并非肿瘤性肺独特。在人类结肠癌异种移植模型中,原发灶被表达argI iNOS low 的TAM包围,而BDMC也表达了argI i iNOS low ,但肺巨噬细胞仅在肿瘤转移至肺部后才采用argI i iNOS low 极化。需要肿瘤的持久性来维持TAM极化。确实,在条件突变型> Kras -和> FGF10 驱动的肺癌模型中,表达转基因的小鼠会形成肺癌,当转基因沉默时,它们会迅速消退。此外,肺巨噬细胞在诱导肿瘤时表达argI high iNOS low ,但随后又返回argI low iNOS low (肿瘤消退后无极化)。操纵TAM功能或消耗TAM可能为预防和治疗多种类型的癌症提供新颖的治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号